Registration Dossier
Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 270-337-8 | CAS number: 68425-17-2
Endpoint summary
Administrative data
Description of key information
Key value for chemical safety assessment
Skin sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
Metabolic data demonstrate that the notifiable substance (identified under the brand name Lycasin® 80/55), as well as the read-across substances (maltose, maltitol, sorbitol, wheat glucose syrup (WGS), and dextrin) share a common metabolic pathway as they are converted to D-glucose and/or sorbitol via hydrolysis of their glycosidic linkages by the intestinal brush border carbohydrases. On the basis of their common mono- and disaccharide metabolites, the properties of the notifiable substance, Lycasin® 80/55 is expected to be similar to the read-across substances maltose, sorbitol, maltitol, WGS and dextrin. Considering this, it is anticipated that exposure to any of the aforementioned saccharides would ultimately result in the formation of D-glucose and/or sorbitol. As such, maltose, sorbitol, maltitol, WGS, and dextrin may be used as appropriate surrogates for Lycasin® 80/55, considering their common metabolic products.
An in vivo skin sensitization study on wheat glucose syrup was identified, which was performed according to OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay) and in compliance with GLP. Under test conditions the substance has been found to be not a skin sensitizer.
Migrated from Short description of key information:
Results of an in vivo skin sensitization study on the read-across substance wheat glucose syrup performed according to test guidelines have demonstrated that the compound is not a skin sensitizer.
Respiratory sensitisation
Endpoint conclusion
- Additional information:
- Migrated from Short description of key information:
There is no information available concerning respiratory or skin sensitisation; data is lacking
Justification for classification or non-classification
Skin sensitization: According to the study run according to OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay), the acceptable read-across compound is non-sensitizing.
There is no information available concerning respiratory or skin sensitisation; data is lacking.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
